CMV and EBV Reactivation after Allogeneic Transplantation

被引：1
|
作者：
Butler, Andrew [1 ]
Thurston, Andrew [2 ]
机构：
[1] Canterbury Hlth Labs, Christchurch, New Zealand
[2] Christchurch Hosp, Christchurch, New Zealand
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.381
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [1] Effect of the donor CMV status on CMV reactivation after allogeneic transplantation
    Nürnberger, W
    Krempe, C
    Steinhagen, G
    Adams, O
    Göbel, U
    BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [2] EBV reactivation after allogeneic transplantation: incidence, risk factors and management
    Kalogiannides, P
    Bartzoudis, D
    Sakellari, I
    Adamidou, D
    Zorbas, I
    Tsompanakou, A
    Douka, V
    Saloum, R
    Fassas, A
    Anagnostopoulos, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S178 - S178
  • [3] How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)
    Brissot, Eolia
    Alsuliman, Tamim
    Gruson, Berengere
    Hermet, Eric
    Tirefort, Yordanka
    Yakoub-Agha, Ibrahim
    Alain, Sophie
    BULLETIN DU CANCER, 2017, 104 (12) : S181 - S187
  • [4] Impact of Single or Associated CMV, EBV and BK Virus Reactivation Early after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse Incidence
    Michallet, Mauricette
    Sobh, Mohamad
    Leroy, Sandrine
    Barraco, Fiorenza
    Thomas, Xavier
    Ducastelle, Sophie
    Lina, Bruno
    Morfin, Florence
    Ader, Florence
    Frobert, Emilie
    Nicolini, Franck E.
    Michallet, Anne-Sophie
    BLOOD, 2014, 124 (21)
  • [5] Impact of single or associated CMV, EBV and BK virus reactivation early after allogeneic hematopoietic stem cell transplantation on relapse incidence
    Michallet, M.
    Sobh, M.
    Leroy, S.
    Barraco, F.
    Thomas, X.
    Ducastelle, S.
    Lina, B.
    Morfin, F.
    Ader, F.
    Frobert, E.
    Nicolni, F. -E.
    Michallet, A. -S.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S407 - S407
  • [6] Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children
    Pukownik, Ewelina
    Kubicka, Malgorzata
    Kurylo-Rafinska, Beata
    Debski, Robert
    Galazka, Przemyslaw
    Czyzewski, Krzysztof
    Krenska, Anna
    Bartoszewicz, Natalia
    Demidowicz, Ewa
    Marjanska, Agata
    Dziedzic, Magdalena
    Pogorzala, Monika
    Wysocki, Mariusz
    Styczynski, Jan
    ANTICANCER RESEARCH, 2018, 38 (10) : 6009 - 6013
  • [7] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
  • [8] EBV-reactivation after allogeneic hematopoietic stem cell transplantation: To treat or not to treat?
    Schoemans, H.
    Theunissen, K.
    Boogaerts, M.
    Maertens, J.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 114 - 114
  • [9] Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation
    Koch, K.
    Herhaus, P.
    Osswald, L.
    Braitsch, K.
    Bassermann, F.
    Verbeek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 62 - 62
  • [10] CMV, EBV and HHV-6 reactivation after allogeneic stem cell transplantation does not linked to viral contamination of apheresis platelet concentrates
    Tsaur, G.
    Vakhonina, L.
    Glebova, T.
    Gerasimova, L.
    Vyatkin, I.
    Maysheva, N.
    Medvedev, O.
    Arakaev, O.
    Fechina, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S244 - S244
12345